4201 articles
With no frames in sight, new practice Illume Eye Care in Ponsonby, Auckland, is open for patients seeking anything from a comprehensive eye exam to specialised care in myopia management, contact lenses and speciality contact lenses, dry eye disease and ocular surface disease management, keratoconus
EssilorLuxottica boosted its myopia portfolio at the recent China International Import Expo in Shanghai, launching Essilor Stellest 2.0 in Greater China, with other key markets to follow in 2026.
University of Auckland medical student Robin Yang is the proud recipient of this year’s Gordon Sanderson Scholarship.
Research from Aspect’s Research Centre for Autism Practice (ARCAP) has identified significant barriers autistic people face when accessing eyecare in Australia and New Zealand.
Topcon Healthcare has signed a definitive agreement to acquire New Zealand-founded AI health-technology company Toku Eyes, now based in San Diego. The acquisition is part of the integration of Toku’s
In a bid to strengthen the pharmacy workforce and remove “unnecessary” regulation, parliament has passed a bill that will scrap one of three pharmacy ownership rules, allowing prescribers to become pharmacy owners.
Corneal Lens Corporation (CLC) is bringing the benefits of time-tested silk proteins in eye-drop form with the launch of Evolve Silk, a preservative-free drop designed to repair the corneal epithelium.
The 2025 ADONZ general meeting saw Laura McLaren elected as president after Courtney Chellew’s term ended. Other changes in the executive committee included the appointment of Genna Morrison as vice
Specsavers New Zealand has released a new range of frames, designed in collaboration with renowned Māori artist Kura Te Waru Rewiri, in support of The Fred Hollows Foundation NZ’s mission to end avoid
Australian optometrists may soon align with their Kiwi counterparts in prescribing oral medicines under proposed changes now open for public consultation.
A Canterbury man with neovascular age-related macular degeneration (nAMD) permanently lost sight in his right eye after a delayed follow-up for anti-VEGF injections, according to a Health and Disability Commissioner (HDC) decision. The delay followed the patient, previously stabilised on aflibercept
US researchers identified two naturally occurring molecules, agmatine and thiamine (vitamin B1), which may serve as biomarkers and therapeutic targets in primary open-angle glaucoma (POAG). Writi